Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment

Clinical and Molecular Hepatology · Published 2026-07-23 · DOI 10.3350/cmh.2026.0258

Free full text

Authors (9)

Nana Peng, Mary Yue Wang, Sherlot Juan Song, Jimmy Che-To Lai, Vicki Wing-Ki Hui, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Mamatha Bhat, Terry Cheuk-Fung Yip

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Peng, N., Wang, M., Song, S., et al. (2026). Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0258

Related articles

• Targeting ER lipid raft-associated 1 reveals a coordinated cholesterol-dependent vulnerability in hepatocellular carcinoma · Clinical and Molecular Hepatology · 2026 · Same journal
• Noncanonical EZH2 activity cooperates with FOXM1 to drive tumorigenesis and advanced progression in HCC · Clinical and Molecular Hepatology · 2026 · Same journal
• Viral load rather than transaminase: an international perspective on the KASL–EALA 2026 guideline for chronic hepatitis B · Clinical and Molecular Hepatology · 2026 · Same journal
• Genetic and Genomic Insights Across the SLD Spectrum · Clinical and Molecular Hepatology · 2026 · Same journal
• Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study · Clinical and Molecular Hepatology · 2026 · Same journal
• Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review · Clinical and Molecular Hepatology · 2026 · Same journal
• Rethinking lean metabolic dysfunction-associated steatotic liver disease: Unrecognized risk in lean populations: Editorial on “Normal-weight metabolic dysfunction-associated steatotic liver disease: Reclassification, characteristics, and adverse liver outcomes across diverse populations” · Clinical and Molecular Hepatology · 2026 · Same journal
• Oncofetal reprogramming in hepatocellular carcinoma: linking developmental programs to cancer vaccines and immunotherapy · Clinical and Molecular Hepatology · 2026 · Same journal
• Interleukin-1β as target to induce synthetic lethality in KRAS mutant biliary tract cancer · Clinical and Molecular Hepatology · 2026 · Same journal
• Mapping lipid droplet viscosity: A novel tool for spatiotemporal ferroptosis imaging: Editorial on “Novel near-infrared probe for monitoring lipid peroxidation-mediated viscosity change in ferroptotic hepatocytes” · Clinical and Molecular Hepatology · 2026 · Same journal